Is 'Moisturol' Up For Grabs? NBC's Faux Nutricosmetic May Be Worth Reconsidering
This article was originally published in The Rose Sheet
Executive Summary
The "Moisturol" pill that Dateline NBC pitched in 2006 to test the integrity of the infomercial industry – because it "could not possibly work as advertised" – is a lot less outrageous today amid a global nutricosmetics boom. The Rose Sheet considers how the faux beauty-from-within innovation might fare with consumers and regulators in 2017.
You may also be interested in...
Anti-Aging Supplement Claims End, Monitoring Of Distributors' Regulatory Compliance Begins
Telomerase Activation Sciences settles with FTC over unsupported claims its supplement and topical could restore aging immune systems, increase bone density and reverse the effects of aging skin. The company sold its supplement for up $2,200 per month and had at least $56m in sales.
Nutricosmetics Pose Intriguing Possibilities For Brands That Hit Wall With Skin-Care Claims
Statements about collagen production, maintaining cellular integrity, addressing age spots, even shrinking wrinkles and treating noncystic acne – all are viable structure/function claims for nutricosmetics, assuming there's evidence to back them up. The Rose Sheet discusses the growing opportunity with regulatory and legal experts and provides an overview of the market at present.
Nutricosmetics Pose Intriguing Possibilities For Brands That Hit Wall With Skin-Care Claims
Statements about collagen production, maintaining cellular integrity, addressing age spots, even shrinking wrinkles and treating noncystic acne – all are viable structure/function claims for nutricosmetics, assuming there's evidence to back them up. The Rose Sheet discusses the growing opportunity with regulatory and legal experts and provides an overview of the market at present.